vTv Therapeutics (VTVT) Tops Q3 EPS by 42c

vTv Therapeutics (NASDAQ: VTVT) reported Q3 EPS of ($0.58), $0.42 better than the analyst estimate of ($1.00).

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• Uber sells part of its Aurora stake in block trade - Bloomberg
• OpenAI pauses frontier model training to strengthen safeguards
• Taylor Devices (TAYD) Misses Q4 EPS by 31c